XOMA Corporation (XOMAP)

US — Healthcare Sector
Peers: XOMAO  FBIOP  FRGAP  OTRKP  RILYP 

Automate Your Wheel Strategy on XOMAP

With Tiblio's Option Bot, you can configure your own wheel strategy including XOMAP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol XOMAP
  • Rev/Share 3.585
  • Book/Share 7.0707
  • PB 3.6827
  • Debt/Equity 1.3524
  • CurrentRatio 5.541
  • ROIC -0.0446

 

  • MktCap 311604912.0
  • FreeCF/Share -0.5034
  • PFCF -51.7187
  • PE -109.01
  • Debt/Assets 0.538
  • DivYield 0.0828
  • ROE -0.0325

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About XOMA Corporation (XOMAP)

  • IPO Date 2020-12-16
  • Website https://www.xoma.com
  • Industry Biotechnology
  • CEO Mr. Owen P. Hughes Jr.
  • Employees 13

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.